CoChat
Sign Up
Cited by 16

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

The M2 Macrophages Importance Role in Psoriasis

Alshihmani, Ahmed Hussein Hasan, Mahmoudi, Mahmoud, Kheder, Ramiar Kamal, Fadaee, Afsane, Esmaeili, Seyed‐Alireza·2025·Immunity, Inflammation and Disease
DOI 10.1002/iid3.70211
Open this paper in CoChat — free account

Abstract

Background: Psoriasis is a chronic autoimmune skin condition that is increasingly prevalent globally, causing significant challenges for affected individuals. The disease is influenced by a combination of genetic factors, environmental triggers, immune system dysfunction, and its systemic nature with comorbidities like cardiovascular diseases and depression. Macrophages, essential immune cells, play a critical role in the pathogenesis of psoriasis, displaying various functions and activation states. Objective: This study aims to investigate the impact of M2 macrophages on the progression and management of psoriasis, particularly their ability to support tissue healing and reduce inflammation. Results: M1 macrophages are involved in early inflammation and pro‐inflammatory responses when activated by LPS and IFN‐γ, while M2 macrophages are activated by IL‐4 and IL‐13 to promote anti‐inflammatory and tissue repair processes. Imbalance in M1 and M2 polarization can worsen autoimmune conditions such as psoriasis, underscoring the need to regulate macrophage phenotypes for effective disease management. Recent research suggests that targeting M2 macrophages could be a promising therapeutic approach for treating psoriasis, especially through advanced biologic treatments such as anti‐IL‐17 and anti‐IL‐23 therapies. Enhancing the function of M2 macrophages has been shown to reduce inflammation and improve outcomes in psoriatic conditions, potentially lowering the risk of comorbidities through early intervention and personalized treatment. Biomarkers like CD163(+) M2 macrophages are associated with disease progression, while treatments that enhance M2 macrophage function, such as PSORI‐CM02 and Treg‐of‐B cell therapies, show potential in alleviating psoriasis symptoms. Conclusion: Understanding the crucial role of M2 macrophages in psoriasis could pave the way for innovative treatment approaches that regulate immune responses and enhance patient care. Further exploration of macrophage biology in psoriasis may provide fresh perspectives on personalized therapeutic options for managing psoriasis and other inflammatory skin conditions, ultimately improving patient care and quality of life for individuals with this chronic skin condition.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/iid3.70211

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 5 references

Research works printed but not linked: 111

  1. 10.3390/biomedicines9111511 · DOI
  2. 10.1016/j.drudis.2020.09.023 · DOI
  3. Fini Z. S., 2022, An Investigation of the Relationship Between HLA‐CW06 and Psoriasis in Iranian Patients Using Sequence‐Specific Primers, International Journal of Medical Laboratory, 9
  4. 10.1038/s41419-022-04523-3 · DOI
  5. 10.2147/CCID.S420850 · DOI
  6. 10.2147/PTT.S327310 · DOI
  7. Dhabale A., 2022, Types of Psoriasis and Their Effects on the Immune System, Cureus, 14
  8. 10.1002/eji.201646774 · DOI
  9. 10.3390/ijms20184347 · DOI
  10. 10.1016/j.jdin.2022.08.008 · DOI
  11. 10.1007/s13671-013-0066-6 · DOI
  12. 10.3390/ijerph13070743 · DOI
  13. 10.3390/jcm8010115 · DOI
  14. 10.1002/jcp.29737 · DOI · Paper page
  15. 10.3390/genes14081619 · DOI
  16. 10.1080/09546634.2023.2193661 · DOI
  17. Kim W. B., 2017, Diagnosis and Management of Psoriasis, Canadian Family Physician Medecin De Famille Canadien, 63, 278
  18. 10.1111/1346-8138.14711 · DOI
  19. 10.3390/life14060733 · DOI
  20. Alshahrani J. A., 2023, A Holistic View of Psoriasis: Examining Its Association With Dyslipidemia and Obesity in a Decade‐Long Systematic Review and Meta‐Analysis, Cureus, 15
  21. 10.3390/ijms241512310 · DOI
  22. 10.1002/acr.23836 · DOI
  23. Lee E. B., 2018, Psoriasis Risk Factors and Triggers, Cutis, 102, 18
  24. Bhagwat A. P., 2023, The Current Advancement in Psoriasis, Cureus, 15
  25. 10.3390/ijms241713313 · DOI
  26. 10.3389/fmed.2022.1027347 · DOI
  27. 10.4103/ijd.ijd_422_23 · DOI
  28. 10.1001/jama.2020.4006 · DOI
  29. 10.1016/j.jaad.2010.11.055 · DOI
  30. 10.2147/PTT.S328460 · DOI
  31. 10.1111/bjd.20940 · DOI
  32. 10.1038/nri1733 · DOI · Paper page
  33. 10.1016/j.immuni.2014.10.008 · DOI
  34. 10.1002/jcp.26429 · DOI · Paper page
  35. 10.1002/jcp.26461 · DOI
  36. 10.1098/rsos.220270 · DOI
  37. 10.1038/nri3073 · DOI · Paper page
  38. 10.1016/j.imbio.2017.11.001 · DOI
  39. 10.3389/fimmu.2019.01084 · DOI · Paper page
  40. 10.3389/fimmu.2019.00792 · DOI · Paper page
  41. 10.1016/j.intimp.2024.111557 · DOI
  42. 10.1016/j.immuni.2010.05.007 · DOI · Paper page
  43. 10.1016/j.it.2004.09.015 · DOI · Paper page
  44. 10.1631/jzus.B2100930 · DOI
  45. 10.3389/fimmu.2019.00792 · DOI · Paper page
  46. 10.12703/P6-13 · DOI · Paper page
  47. 10.1038/nri2448 · DOI · Paper page
  48. 10.1172/JCI59643 · DOI · Paper page
  49. 10.3389/fimmu.2014.00614 · DOI
  50. 10.1042/CS20220531 · DOI
  51. 10.3389/fphys.2012.00056 · DOI
  52. 10.1038/s41423-020-00558-8 · DOI · Paper page
  53. 10.1016/j.cell.2014.11.023 · DOI · Paper page
  54. 10.1016/j.crmeth.2022.100192 · DOI
  55. 10.1126/science.1068883 · DOI · Paper page
  56. 10.1038/nature01320 · DOI · Paper page
  57. 10.1016/S0952-7915(00)00180-1 · DOI
  58. 10.1111/j.0105-2896.2005.00301.x · DOI
  59. 10.1038/nri2103 · DOI
  60. 10.1016/j.immuni.2016.02.015 · DOI · Paper page
  61. 10.3390/ijms19123805 · DOI · Paper page
  62. 10.1371/journal.pone.0145342 · DOI · Paper page
  63. Ahmed I., 2020, M1 and M2 Macrophages Polarization via mTORC1 Influences Innate Immunity and Outcome of Ehrlichia Infection, Journal of Cellular Immunology, 2, 108
  64. 10.3390/antiox11071394 · DOI · Paper page
  65. 10.1155/2023/8821610 · DOI
  66. 10.18632/oncotarget.10561 · DOI · Paper page
  67. 10.1038/nature12034 · DOI · Paper page
  68. 10.3389/fimmu.2019.01462 · DOI · Paper page
  69. 10.3389/fimmu.2019.02993 · DOI
  70. 10.2337/db14-0929 · DOI
  71. 10.1186/s12974-024-03078-8 · DOI
  72. 10.1371/journal.pone.0074676 · DOI
  73. 10.1038/s41419-022-04775-z · DOI
  74. 10.1016/j.immuni.2014.06.008 · DOI · Paper page
  75. 10.3389/fimmu.2023.1080310 · DOI
  76. Kong X., 2021, Characteristics and Clinical Significance of CD163+/CD206+ M2 Mono‐Macrophage in the Bladder Cancer Microenvironment, Turkish Journal of Biology = Turk Biyoloji Dergisi, 45, 624
  77. 10.3390/cells9051175 · DOI
  78. 10.3390/cancers14143331 · DOI
  79. 10.3389/fimmu.2022.840029 · DOI
  80. Galván‐Peña S., 2014, Metabolic Reprograming in Macrophage Polarization, Frontiers in Immunology, 5, 420
  81. 10.3389/fphys.2018.00419 · DOI
  82. 10.1002/mco2.349 · DOI
  83. 10.1155/2018/8917804 · DOI · Paper page
  84. 10.1038/nri3088 · DOI · Paper page
  85. 10.1038/ni.1937 · DOI · Paper page
  86. 10.1002/cbf.3981 · DOI
  87. 10.1111/imm.12910 · DOI · Paper page
  88. 10.1186/s12950-023-00360-z · DOI
  89. 10.1016/j.biopha.2023.114469 · DOI · Paper page
  90. 10.3389/fimmu.2017.00303 · DOI
  91. 10.3390/ijms25105306 · DOI
  92. 10.1007/s10753-024-01994-8 · DOI
  93. 10.7150/thno.89180 · DOI
  94. 10.4172/2155-9899.1000371 · DOI
  95. 10.3389/fcell.2022.839248 · DOI
  96. 10.3389/fimmu.2023.1219487 · DOI
  97. 10.1007/978-3-030-55035-6_6 · DOI
  98. 10.1016/j.jdermsci.2022.07.003 · DOI
  99. 10.3390/cells12020276 · DOI
  100. 10.1007/BF02505293 · DOI
  101. 10.1016/j.jdermsci.2012.07.007 · DOI
  102. 10.1002/art.24406 · DOI
  103. 10.1016/j.lfs.2019.117231 · DOI
  104. 10.1111/jcmm.17748 · DOI
  105. 10.2147/JIR.S398862 · DOI
  106. 10.4049/jimmunol.1600446 · DOI
  107. 10.1016/j.clim.2014.11.006 · DOI
  108. Lu C.‐H., 2018, Involvement of M1 Macrophage Polarization in Endosomal Toll‐Like Receptors Activated Psoriatic Inflammation, Mediators of Inflammation, 2018, 1
  109. 10.3389/fmed.2021.625130 · DOI
  110. 10.1111/exd.14059 · DOI
  111. 10.1155/2020/4548012 · DOI

Cited by

Sorted by citations

See all 16

Metadata

Authors
Alshihmani, A. H. H., Mahmoudi, M., Kheder, R. K., Fadaee, A., & Esmaeili, S.
Affiliations
  • Immunology Research Center Mashhad University of Medical Sciences Mashhad Iran
  • Medical Laboratory Science Department, College of Science University of Raparin Rania Sulaymaniyah Iraq
ORCID
Esmaeili, Seyed‐Alireza
Venue
Immunity, Inflammation and Disease
Publisher
Wiley
Published
2025-06
Volume
13
Issue
6
ISSN
2050-4527
DOI
10.1002/iid3.70211
Cited by
16
References
5
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (vor, 19 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review